Zobrazeno 1 - 10
of 639
pro vyhledávání: '"Burnett Ak"'
Autor:
Lin WY, Fordham SE, Hungate E, Sunter NJ, Elstob C, Xu Y, Park C, Quante A, Strauch K, Gieger C, Skol A, Rahman T, Sucheston-Campbell L, Wang J, Hahn T, Clay-Gilmour AI, Jones GL, Marr HJ, Jackson GH, Menne T, Collin M, Ivey A, Hills RK, Burnett AK, Russell NH, Fitzgibbon J, Larson RA, Le Beau MM, Stock W, Heidenreich O, Alharbi A, Allsup DJ, Houlston RS, Norden J, Dickinson AM, Douglas E, Lendrem C, Daly AK, Palm L, Piechocki K, Jeffries S, Bornhäuser M, Röllig C, Altmann H, Ruhnke L, Kunadt D, Wagenführ L, Cordell HJ, Darlay R, Andersen MK, Fontana MC, Martinelli G, Marconi G, Sanz MA, Cervera J, Gómez-Seguí I, Cluzeau T, Moreilhon C, Raynaud S, Sill H, Voso MT, Lo-Coco F, Dombret H, Cheok M, Preudhomme C, Gale RE, Linch D, Gaal-Wesinger J, Masszi A, Nowak D, Hofmann WK, Gilkes A, Porkka K, Milosevic Feenstra JD, Kralovics R, Grimwade D, Meggendorfer M, Haferlach T, Krizsán S, Bödör C, Stölzel F, Onel K, Allan JM
Publikováno v:
NATURE COMMUNICATIONS
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Acute myeloid leukemia (AML) is a hematological malignancy with an undefined heritable risk. Here we perform a meta-analysis of three genome-wide association studies, with replication in a fourth study, incorporating a total of 4018 AML cases and 104
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::a87982b6c8c04fd9ebef07800bdebdba
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=15221
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=15221
Autor:
Burnett, AK, Gupta, ED, Knapper, S, Khwaja, A, Sweeney, M, Kjeldsen, L, Hawkins, T, Betteridge, SE, Cahalin, P, Clark, RE, Hills, RK, Russell, NH
As part of the UK NCRI AML17 trial, adult acute myeloid leukaemia patients in remission could be randomised to receive the mTOR inhibitor everolimus, sequentially with post-induction chemotherapy. Three hundred and thirty-nine patients were randomise
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::e2f167d2e8343b093fd1067b66413933
https://doi.org/10.3324/haematol.2018.189514
https://doi.org/10.3324/haematol.2018.189514
Autor:
Grimwade, D, Diverio, D, Harrison, G, Wheatley, AK, Rodgers, J, Lo Coco, F, Goldstone, AH, Solomon, E, Burnett, AK
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::5590227dfbc7046786f4357deed47032
https://ora.ox.ac.uk/objects/uuid:c3158c3a-e531-4fc4-ae0b-c6adc56ea6c9
https://ora.ox.ac.uk/objects/uuid:c3158c3a-e531-4fc4-ae0b-c6adc56ea6c9
Autor:
Grimwade, D, Walker, H, Oliver, F, Chatters, S, Harrison, G, Wheatley, K, Burnett, AK, Goldstone, AH, Party, MRCALW
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::b4ac7010ebad255e800439df1a0a65e7
https://ora.ox.ac.uk/objects/uuid:ca9b0da4-8961-4f38-8823-70b2c14265bb
https://ora.ox.ac.uk/objects/uuid:ca9b0da4-8961-4f38-8823-70b2c14265bb
Autor:
Rowe, JM, Richards, SM, Burnett, AK, Wiernik, PH, Harrison, G, Lazarus, HM, Franklin, IM, Prentice, GH, Durrant, JI, Tallman, MS, Goldstone, AH
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::083e8ce6fa128660acabd79249047765
https://ora.ox.ac.uk/objects/uuid:094b37d6-87f1-4e41-8bed-b1392bf0115c
https://ora.ox.ac.uk/objects/uuid:094b37d6-87f1-4e41-8bed-b1392bf0115c
Autor:
Peniket, AJ, Wainscoat, JS, Wheatley, K, Side, LE, Boultwood, J, Walker, H, Harrison, CJ, Goldstone, AH, Burnett, AK
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::7fec55ec8bd1df0feef0870ea233183d
https://ora.ox.ac.uk/objects/uuid:881bd054-475d-4210-9977-7b53626a32d7
https://ora.ox.ac.uk/objects/uuid:881bd054-475d-4210-9977-7b53626a32d7
Autor:
Dohner, H, Estey, EH, Amadori, S, Appelbaum, FR, Buchner, T, Burnett, AK, Dombret, H, Fenaux, P, Grimwade, D, Larson, RA, Lo-Coco, F, Naoe, T, Niederwieser, D, Ossenkoppele, GJ, Sanz, MA, Sierra, J, Tallman, MS, Lowenberg, B, Bloomfield, CD
Publikováno v:
BLOOD
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
In 2003, an international working group last reported on recommendations for diagnosis, response assessment, and treatment outcomes in acute myeloid leukemia (AML). Since that time, considerable progress has been made in elucidating the molecular pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::77d72c84e39b5b9b1d3148111cbf0ce3
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=12855
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=12855
Autor:
Burnett Ak, Dorak Mt
Publikováno v:
Cancer Causes and Control. 3:273-282
In experimental models, leukemia was the first disease shown to have an association with the major histocompatibility complex (MHC) genes. In humans, several allelic human-leukocyte antigen (HLA) associations also have been recognized. In addition to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::839ef1ec4dc3a35a717bb3054b2c86d4
https://doi.org/10.1007/bf00124261
https://doi.org/10.1007/bf00124261
Autor:
Burnett Ak
Publikováno v:
Leukemia & Lymphoma. 7:39-43
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::803d843607b35b9c87ba86395018bcd9
https://doi.org/10.3109/10428199209061563
https://doi.org/10.3109/10428199209061563